The highest target so far is $21? If it does become a billion dollar drug we can do the math. Is it 3X sales that gives the high end price targets? CEMP could actually be worth $40 a share on a buy out if it were to actually be that huge of a drug do to the off -labeling for its anti-inflammatory properties ( liver,etc). Realistically I see $30 very easy since there second antibiotic is actually on the market in other countries for yrs and is a sure thing to bring in 200,000 a yr eventually. Peeps will be on that drug for their whole life. CEMP is so cheap its insane.